Article
Anticancer activity of 3-demethylubiquinone Q2. In vivo experiments and probable mechanism of action.
Anticancer research - 1 Jan 2000
Fedorov Sergey N, Radchenko Oleg S, Shubina Larisa K, Balaneva Nadezda N, Agafonova Irina G, Bode Ann M, Jin Jun-O, Kwak Jong-Young, Dong Zigang, Stonik Valentin A
Abstract excerpt
BACKGROUND: 3-Demethylubiquinone Q2 (3DMUbQ2), isolated from the ascidian Aplidium glabrum and later synthesized, is known as a natural product inhibiting EGF-induced malignant JB6 P+ Cl 41 cell transformation. However, its in vivo anticancer properties and probable mechanism of this action have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
